Evidence map›Paper›PMID 29059381›Full record

ArticleThe Journal of clinical endocrinology and metabolism2018

Ossifications in Albright Hereditary Osteodystrophy: Role of Genotype, Inheritance, Sex, Age, Hormonal Status, and BMI.

Parissa Salemi, Julie M Skalamera Olson, Lauren E Dickson, Emily L Germain-Lee

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00209235 (Natural History Study of Albright Hereditary Osteodystrophy), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00209235 naactive not recruitingnot on this map

Natural History Study of Albright Hereditary Osteodystrophy: Includes Substudies on Effects of Growth Hormone in Patients With Pseudohypoparathyroidism Type 1A and Cognitive & Behavioral Studies in Albright Hereditary Osteodystrophy

TypeinterventionalSponsorConnecticut Children's Medical CenterRan2003 to 2030Enrolled600ConditionsPseudohypoparathyroidism Type 1A, Albright Hereditary Osteodystrophy, PseudopseudohypoparathyroidismArmsNeurocognitive and psychosocial testing
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Approach to the patient: genetics and management of congenital hypothyroidism.The Journal of clinical endocrinology and metabolism · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. A novelClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2024
    Article
  9. Frontiers in endocrinology · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Parental Origin ofJBMR plus · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Management of pseudohypoparathyroidism.Current opinion in pediatrics · 2019
    Review
  18. Pseudohypoparathyroidism.Endocrinology and metabolism clinics of North America · 2018
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Parissa SalemiDepartment of Pediatrics, Division of Pediatric Endocrinology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Julie M Skalamera OlsonAlbright Clinic, Kennedy Krieger Institute, Baltimore, Maryland.
Lauren E DicksonAlbright Center and Center for Rare Bone Disorders, Division of Pediatric Endocrinology & Diabetes, Connecticut Children's Medical Center, Farmington, Connecticut.
Emily L Germain-LeeDepartment of Pediatrics, Division of Pediatric Endocrinology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Connecticut Children's Medical Center · USJohns Hopkins University · USKennedy Krieger Institute · US

Funding

ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BELCHER, HAROLYN MILLICENT EDITH · 1985 to 2007
$37.3M
The role of G protein-coupled signaling in neurocognitive and psychosocialabnormalitiesR21HD078864 · NICHD · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GERMAIN-LEE, EMILY L · 2016 to 2017
$451k
FDA HHS R01 FD002568FDA HHS R01 FD003409NCRR NIH HHS M01 RR000052NICHD NIH HHS R21 HD078864
6 · The paper itself

Abstract

Context: Albright hereditary osteodystrophy (AHO) is caused by heterozygous inactivating mutations in GNAS. Depending on the parental origin of the mutated allele, patients develop either pseudohypoparathyroidism type 1A (PHP1A), with multihormone resistance and severe obesity, or pseudopseudohypoparathyroidism (PPHP), without hormonal abnormalities or marked obesity. Subcutaneous ossifications (SCOs) are a source of substantial morbidity in both PHP1A and PPHP. Objective: This study investigated the previously undetermined prevalence of SCO formation in PHP1A vs PPHP as well as possible correlations with genotype, sex, age, hormonal resistance, and body mass index (BMI). Design: This study evaluated patients with AHO for SCOs by physical examination performed by one consistent physician over 16 years. Setting: Albright Clinic, Kennedy Krieger Institute; Institute for Clinical and Translational Research, Johns Hopkins Hospital; Albright Center, Connecticut Children's Medical Center. Patients: We evaluated 67 patients with AHO (49 with PHP1A, 18 with PPHP) with documented mutations in GNAS. Main Outcome Measures: Relationships of SCOs to genotype, sex, age, hormonal resistance, and BMI. Results: Forty-seven of 67 participants (70.1%) had SCOs. Patients with PHP1A and PPHP had similar prevalences and degrees of ossification formation. Patients with frameshift and nonsense mutations had much more extensive SCOs than those with missense mutations. Males were affected more than females. There was no correlation with hormonal status or BMI. Conclusions: There is a similar prevalence of SCOs in PHP1A and PPHP, and the extent of SCO formation correlates with the severity of the mutation. Males are affected more extensively than females, and the SCOs tend to worsen with age.

Indexed as

Body Mass IndexInheritance PatternsMutationOsteogenesisAdolescentAdultAge FactorsBiomarkersChildChild, PreschoolChromograninsFemaleFollow-Up StudiesGenotypeGTP-Binding Protein alpha Subunits, GsHormonesBiomarkersChromograninsGNAS protein, humanGTP-Binding Protein alpha Subunits, GsHormones

Identifiers

PMID29059381
PMCPMC5761497
OpenAlexW2766135242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.